Breaking News Instant updates and real-time market news.

AVXS

AveXis

$211.85

0.68 (0.32%)

13:00
04/12/18
04/12
13:00
04/12/18
13:00

AveXis attracts far downside put buyers as shares reach 52-week highs

AveXis attracts far downside put buyers as shares reach 52-week highs. The stock up $1.20 to $213.05 and Aug 150 puts trade for $2.40 and 2.50. More than 5K trade so far and the bearish flow will open the largest open interest block in the name. The strike is 30% below spot and captures earnings in early-May and August. June 2017 52-week low is $67.48 and 68.3% from current levels.

  • 03

    May

AVXS AveXis
$211.85

0.68 (0.32%)

04/10/18
SBSH
04/10/18
DOWNGRADE
SBSH
Neutral
AveXis downgraded to Neutral from Buy at Citi
CIit analyst Mohit Bansa downgraded AveXis (AVXS) following the company's agreement to be acquired by Novartis (NVS). The analyst in late January called AveXis an "interesting" takeover target. His buyout valuation was $185 per share without extra credit to the pipeline and $250 per share when including a 25% probability to Rhett and 25% extra probability to spinal muscular atrophy type 2. Novartis is buying the company for $218 per share or $8.7B in cash.
04/11/18
FBCO
04/11/18
DOWNGRADE
Target $218
FBCO
Neutral
AveXis downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst Martin Auster downgraded AveXis (AVXS) to Neutral from Outperform and raised his price target on the shares to $218 from $170 ahead of likely closing of the Novartis (NVS) deal.
04/12/18
UBSW
04/12/18
DOWNGRADE
Target $218
UBSW
Neutral
AveXis downgraded to Neutral from Buy at UBS
UBS analyst Carter Gould downgraded AveXis (AVXS) to Neutral while raising his price target for the shares to $218 from $143. The analyst has confidence the takeover by Novartis (NVS) will close, and notes the shares are within 5% of the $218 offer price. The chance of antitrust concerns arising are remote, Gould tells investors in a research note.
04/12/18
LEHM
04/12/18
DOWNGRADE
Target $218
LEHM
Equal Weight
AveXis downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Gena Wang downgraded AveXis (AVXS) to Equal Weight to reflect the proposed takeover by Novartis (NVS). The analyst sees limited antitrust risks and a low probability of a counterbid. She raised her price target for AveXis shares to $218 from $152. She believes the price being paid by Novartis fully reflects the value of the stock.

TODAY'S FREE FLY STORIES

BKU

BankUnited

09:17
04/26/18
04/26
09:17
04/26/18
09:17
Upgrade
BankUnited rating change  »

BankUnited upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UPS

UPS

09:17
04/26/18
04/26
09:17
04/26/18
09:17
Hot Stocks
Breaking Hot Stocks news story on UPS »

UPS says confident a deal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

COP

ConocoPhillips

09:17
04/26/18
04/26
09:17
04/26/18
09:17
Downgrade
ConocoPhillips rating change  »

ConocoPhillips downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 07

    May

  • 22

    May

  • 30

    May

ABBV

AbbVie

09:16
04/26/18
04/26
09:16
04/26/18
09:16
Hot Stocks
Breaking Hot Stocks news story on AbbVie »

AbbVie says 'highly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 27

    Apr

  • 08

    May

  • 21

    May

  • 05

    Jun

AAL

American Airlines

09:16
04/26/18
04/26
09:16
04/26/18
09:16
Hot Stocks
Breaking Hot Stocks news story on American Airlines »

American Airlines: EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Jun

PLUS

ePlus

09:16
04/26/18
04/26
09:16
04/26/18
09:16
Hot Stocks
ePlus ePlus announces 500,000 share stock repurchase program »

ePlus announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCO

Taubman Centers

09:15
04/26/18
04/26
09:15
04/26/18
09:15
Hot Stocks
Land & Buildings sends letter to Taubman Centers shareholders »

Land & Buildings sent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

RTN

Raytheon

, LMT

Lockheed Martin

$329.23

-7.14 (-2.12%)

09:15
04/26/18
04/26
09:15
04/26/18
09:15
Recommendations
Raytheon, Lockheed Martin, General Dynamics, Northrop Grumman analyst commentary  »

Defense weakness due to…

RTN

Raytheon

LMT

Lockheed Martin

$329.23

-7.14 (-2.12%)

GD

General Dynamics

$214.53

-7.51 (-3.38%)

NOC

Northrop Grumman

$333.06

-7.94 (-2.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 30

    May

ALGT

Allegiant Travel

$143.35

-0.1 (-0.07%)

09:15
04/26/18
04/26
09:15
04/26/18
09:15
Upgrade
Allegiant Travel rating change  »

Allegiant Travel upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COLB

Columbia Banking

$44.76

0.05 (0.11%)

09:14
04/26/18
04/26
09:14
04/26/18
09:14
Earnings
Columbia Banking reports Q1 EPS 55c, consensus 65c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 12

    Jun

FB

Facebook

$159.69

0.03 (0.02%)

09:14
04/26/18
04/26
09:14
04/26/18
09:14
Recommendations
Facebook analyst commentary  »

Facebook remains favorite…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIEN

Sientra

$12.91

-0.88 (-6.38%)

09:11
04/26/18
04/26
09:11
04/26/18
09:11
Recommendations
Sientra analyst commentary  »

Sientra price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAH

Booz Allen

$39.82

-0.31 (-0.77%)

09:11
04/26/18
04/26
09:11
04/26/18
09:11
Hot Stocks
Booz Allen is added to $998M contract award from the AFMC »

The 96 Test Wing verifies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 29

    May

CFR

Cullen/Frost

$109.66

0.22 (0.20%)

09:11
04/26/18
04/26
09:11
04/26/18
09:11
Earnings
Cullen/Frost reports Q1 EPS $1.61, consensus $1.48 »

Reports Q1 loan loss…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 14

    May

ABBV

AbbVie

$91.91

0.57 (0.62%)

09:10
04/26/18
04/26
09:10
04/26/18
09:10
Hot Stocks
Breaking Hot Stocks news story on AbbVie »

AbbVie says believes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 27

    Apr

  • 08

    May

  • 21

    May

  • 05

    Jun

ABBV

AbbVie

$91.91

0.57 (0.62%)

09:09
04/26/18
04/26
09:09
04/26/18
09:09
Hot Stocks
Breaking Hot Stocks news story on AbbVie »

AbbVie says to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 27

    Apr

  • 08

    May

  • 21

    May

  • 05

    Jun

SCG

Scana

$36.56

0.78 (2.18%)

09:09
04/26/18
04/26
09:09
04/26/18
09:09
Upgrade
Scana rating change  »

Scana upgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSL

MidSouth Bancorp

$13.45

-0.15 (-1.10%)

09:08
04/26/18
04/26
09:08
04/26/18
09:08
Earnings
MidSouth Bancorp reports Q1 adj. EPS 21c, consensus (8c) »

Reports Q1 tier 1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

F

Ford

$11.11

0.16 (1.46%)

09:08
04/26/18
04/26
09:08
04/26/18
09:08
Recommendations
Ford analyst commentary  »

Ford showing urgency to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

MTH

Meritage Homes

$43.43

0.625 (1.46%)

09:08
04/26/18
04/26
09:08
04/26/18
09:08
Recommendations
Meritage Homes analyst commentary  »

Meritage Homes price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

MATR

Mattersight

$2.15

-0.1 (-4.44%)

, NICE

Nice Systems

$93.85

-1.34 (-1.41%)

09:07
04/26/18
04/26
09:07
04/26/18
09:07
Recommendations
Mattersight, Nice Systems analyst commentary  »

Lake Street does not…

MATR

Mattersight

$2.15

-0.1 (-4.44%)

NICE

Nice Systems

$93.85

-1.34 (-1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

  • 29

    May

GM

General Motors

$38.10

0.18 (0.47%)

09:07
04/26/18
04/26
09:07
04/26/18
09:07
Earnings
GM continues to see FY18 adjusted EPS in 'mid-$6' range, consensus $6.33 »

GM continues to project…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 20

    Jun

ORI

Old Republic

$21.22

-0.075 (-0.35%)

09:07
04/26/18
04/26
09:07
04/26/18
09:07
Earnings
Old Republic reports Q1 EPS 1c, may not compare to consensus 41c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

ALGN

Align Technology

$245.24

5.72 (2.39%)

09:05
04/26/18
04/26
09:05
04/26/18
09:05
Recommendations
Align Technology analyst commentary  »

Align Technology price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 12

    Jun

ABBV

AbbVie

$91.91

0.57 (0.62%)

09:05
04/26/18
04/26
09:05
04/26/18
09:05
Hot Stocks
AbbVie says Q1 results 'well ahead of our expectations' »

Says "pleased"…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 27

    Apr

  • 08

    May

  • 21

    May

  • 05

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.